← Leaderboards
Vadivel Ganapathy
Texas Tech University Health Scis Center
$5,868,327
Attributed
$5,868,327
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $573.8K · FY2006–24$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,868,327 · 8
By mechanism
R01$4,201,977 · 3
R21$1,666,350 · 4
P50$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Texas Tech University Health Scis Center
Same institution · by research overlap
- Shafiq A Khan$15,431,955
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularIn VivoCellsMediatingCoupledIn VitroGenesBasePublic Health RelevanceMalignant Breast NeoplasmKnockout MiceTumorMouse ModelMaintenanceLinkWild Type MousePhenotypeSignal TransductionLogicAzoxymethanePathway InteractionsEpigenetic ProcessAutomobile DrivingColon Carcinoma
Grant awards (23)
Amino acid transporter SLC38A5 as a drug target for TNBC: Evaluation with genetic and pharmacologic approaches$169,877
R21 · FY2024 · CA · contact PI
Amino acid transporter SLC38A5 as a drug target for TNBC: Evaluation with genetic and pharmacologic approaches$214,583
R21 · FY2023 · CA · contact PI
SLC5A8 is a conditional tumor suppressor in colon linked to dietary fiber content$339,316
R01 · FY2019 · CA · contact PI
SLC5A8 is a conditional tumor suppressor in colon linked to dietary fiber content$349,811
R01 · FY2018 · CA · contact PI
SLC5A8 is a conditional tumor suppressor in colon linked to dietary fiber content$349,811
R01 · FY2017 · CA · contact PI
SLC5A8 is a conditional tumor suppressor in colon linked to dietary fiber content$349,811
R01 · FY2016 · CA · contact PI
SLC5A8 is a conditional tumor suppressor in colon linked to dietary fiber content$363,061
R01 · FY2015 · CA · contact PI
Retinal Iron Homeostasis in Health and Disease$335,160
R01 · FY2013 · EY · contact PI
Retinal Iron Homeostasis in Health and Disease$355,566
R01 · FY2012 · EY · contact PI
Retinal Iron Homeostasis in Health and Disease$355,485
R01 · FY2011 · EY · contact PI
"Starve the Tumor Cells to Death": SLC6A14 as a Drug Target for Colon Cancer$155,068
R21 · FY2011 · CA · contact PI
Retinal Iron Homeostasis in Health and Disease$381,956
R01 · FY2010 · EY · contact PI
"Starve the Tumor Cells to Death": SLC6A14 as a Drug Target for Colon Cancer$191,835
R21 · FY2010 · CA · contact PI
Molecular Analysis of a Novel Opioid Peptide Transporter$142,737
R21 · FY2007 · DA · contact PI
Molecular Analysis of a Novel Opioid Peptide Transporter$146,500
R21 · FY2006 · DA · contact PI
CARNITINE TRANSPORTERS: STRUCTURE, FUNCTION ®ULATION$255,500
R01 · FY2003 · HL
Immune Tolerance;Sigma Receptor as a Therapeutic Target$215,250
R21 · FY2003 · AI
CARNITINE TRANSPORTERS: STRUCTURE, FUNCTION ®ULATION$255,500
R01 · FY2002 · HL
Immune Tolerance;Sigma Receptor as a Therapeutic Target$215,250
R21 · FY2002 · AI
OCT3 in Drug Pharmacokinetics During Pregnancy$0
P50 · FY2002 · HD
CARNITINE TRANSPORTERS: STRUCTURE, FUNCTION ®ULATION$255,500
R01 · FY2001 · HL
Immune Tolerance;Sigma Receptor as a Therapeutic Target$215,250
R21 · FY2001 · AI
CARNITINE TRANSPORTERS: STRUCTURE, FUNCTION ®ULATION$255,500
R01 · FY2000 · HL